Given that disruptions in EGF signaling have been implicated in PCOS pathogenesis, this study aims to investigate EPI levels in patients with PCOS to elucidate its potential role in the pathophysiology of the disorder, offering insights into its underlying mechanisms and possible therapeutic implications. The gene discussed is EGF; the disease is polycystic ovary syndrome.